Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions

Journal of Clinical Investigation(2023)10.1172/jci164348Source: DataRank Database

Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.20)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Michela Perego ORCID,Yulia Nefedova ORCID,Cindy Lin ORCID,Andrew T. Milcarek ORCID,Peter Vogel ORCID

Live enrichment

PubMed:36892943 PMC:PMC10104898 OpenAlex:https://openalex.org/W4323652132

National Institutes of Health

Grant: R35 CA220446

National Institutes of Health

Grant: R50 CA211199

Mary Kay Ash Foundation

Grant: Mary Kay Ash Foundation

NCI NIH HHS

Grant: P30 CA010815

National Institutes of Health

Grant: 5R50CA211199-04

Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level

National Institutes of Health

Grant: 5R35CA220446-05

Tumor Plasticity

FWCI

1.20

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttp://www.jci.org/articles/view/164348/files/pdf

publisherhttp://www.jci.org/articles/view/164348/files/pdf

publisherhttps://www.jci.org/articles/view/164348/files/pdf

journalhttps://doi.org/10.1172/jci164348

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36892943

Fields of Study

Extracellular vesicles in diseaseCancer Cells and MetastasisImmune cells in cancer03 medical and health sciences0302 clinical medicineHumansFemaleHomozygoteHypoxia-Inducible Factor 1, alpha SubunitImmune EvasionSequence DeletionNeoplasm Recurrence, LocalBreast Neoplasms

MeSH Terms

Breast NeoplasmsFemaleHomozygoteHumansNeoplasm Recurrence, LocalSequence DeletionHypoxia-Inducible Factor 1, alpha SubunitImmune Evasion

Keywords

Breast cancerCancer researchBiologyProgenitor cellMammary glandMyeloidHIF1ADuctal carcinomaCancerAngiogenesisBreast diseasePathologyStem cellMedicineCell biologyNeutrophilsHypoxiaOncologyHomozygoteRBreast NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitHumansFemaleNeoplasm Recurrence, LocalResearch ArticleImmune EvasionSequence Deletion

Sustainable Development Goals

SDG 0: Good health and well-being

Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions

FAIR Checklist

Authors (9)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)